Raafat Seifeldin

TL;DR: Aspergillosis affects a wide range of patient groups and has a negative economic impact across many DRGs, and improved prevention, diagnosis, and patient management strategies can help mitigate these effects on hospital financial performance.

TL;DR: Among these patients with residual urgency after treatment with tolterodine ER 4 mg, solifenacin was associated with significant improvements in urgency and other diary-documented symptoms of overactive bladder.

TL;DR: In this analysis of data from a clinical study in adults and children undergoing HSCT, micafungin prophylaxis was associated with reduced hospital costs, and resultant total patient costs, compared with fluconazole prophYLaxis.

TL;DR: Overall, solifenacin 5/10 mg/day improved work productivity, activity participation, and reduced medical care use in OAB patients who continued to have urgency symptoms with tolterodine ER 4’smg and wished to switch to sol ifenac in 12 weeks.

TL;DR: The treated prevalence of individuals seeking treatment for OAB in the elderly Medicare population is comparable to some common chronic conditions in that population, and OAB-attributable CMS expenditures are considerable, however, due to study limitations this is a conservative estimate of the direct cost of OABIn the elderly population.